The maintenance dose of buprenorphine HCl and naloxone HCl sublingual tablets is generally in the range of 4 mg/1 mg buprenorphine/naloxone to 24 mg/6 mg buprenorphine/naloxone per day depending on the individual patient. Dosages higher than this have not been demonstrated to provide any clinical advantage.
Greylisting is a term used by services such as URIBL to designate aspects of sender reputation and overall deliverability. Currently, URIBL maintains a set of whitelists, blacklists and greylists. According to URIBL's website, a greylist is defined as:
A whitelist is a list or register of entities that provide a particular privilege, service, mobility, access or recognition. Entities on the list will be accepted, approved and/or recognized. Whitelisting is the reverse of blacklisting, the practice of identifying entities that are denied, unrecognised, or ostracised.